Can Human Papillomavirus (HPV) cause Pelvic Inflammatory Disease (PID) in a female of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Does Not Cause Pelvic Inflammatory Disease

HPV is not a causative agent of PID; it is merely found as a concomitant infection in some women with PID, particularly those who are HIV-positive. The established causative organisms of PID are Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and bacterial vaginosis-associated anaerobes 1, 2, 3, 4.

The Evidence on HPV and PID

HPV as a Co-infection, Not a Cause

The CDC guidelines explicitly clarify that in HIV-infected women with PID, microbiologic findings show higher rates of concomitant HPV infections and HPV-related cytologic abnormalities, but this represents co-infection rather than causation 5. The key distinction is:

  • HPV was found at higher rates in HIV-positive women with PID compared to HIV-negative women with PID 5
  • This association reflects shared risk factors (sexual transmission) rather than HPV causing the upper genital tract infection
  • The actual causative organisms remained the same regardless of HPV presence 5

True Causative Organisms of PID

All PID treatment regimens must cover the established causative pathogens: N. gonorrhoeae, C. trachomatis, anaerobes, gram-negative facultative bacteria, and streptococci 1, 2, 4. This microbiologic requirement for treatment underscores that these—not HPV—are the organisms responsible for the infection.

The polymicrobial nature of PID includes 3, 4, 6:

  • Chlamydia trachomatis and Neisseria gonorrhoeae (most common sexually transmitted causes)
  • Bacterial vaginosis-associated organisms (predominantly anaerobes)
  • Mycoplasma genitalium
  • Enteric gram-negative bacteria
  • Respiratory pathogens in rare cases

Clinical Implications

Why This Distinction Matters

Understanding that HPV does not cause PID is critical because:

  • Treatment decisions: PID requires broad-spectrum antibiotics targeting bacteria, not antiviral therapy 1, 2
  • Prevention strategies: PID prevention focuses on screening for C. trachomatis and N. gonorrhoeae, not HPV vaccination 3
  • Partner management: Sex partners require empiric treatment for gonorrhea and chlamydia, regardless of HPV status 1, 2

The HPV-Cervical Cancer Connection

While HPV does not cause PID, one study suggested that women with PID may have higher HPV prevalence (33.74% vs 26.40%), potentially indicating increased cervical cancer risk 7. However, this reflects:

  • Shared sexual transmission routes
  • Common risk factors (multiple partners, young age, lack of barrier contraception)
  • Not a causal relationship between PID and HPV acquisition

Common Pitfall to Avoid

Do not delay or modify PID treatment based on HPV status. The presence or absence of HPV infection should not influence:

  • The decision to treat for PID 2
  • The choice of antibiotic regimen 1, 2
  • The urgency of initiating therapy 2

The CDC maintains a low threshold for empiric PID treatment in any sexually active woman with uterine/adnexal tenderness or cervical motion tenderness, without waiting for any confirmatory testing including HPV 2.

References

Guideline

Cervicitis and Pelvic Inflammatory Disease Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Pelvic Inflammatory Disease (PID)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012

Research

Pelvic inflammatory disease is a risk factor for cervical cancer.

European journal of gynaecological oncology, 2003

Related Questions

What is the recommended treatment for a sexually active woman with pelvic inflammatory disease (PID), particularly those with a history of sexually transmitted infections?
What is the recommended treatment for Pelvic Inflammatory Disease (PID) in the absence of gonorrhea?
How do you know if Pelvic Inflammatory Disease (PID) has resolved?
What is the appropriate initial antibiotic treatment for a sexually active 29-year-old woman presenting with lower abdominal pain, fevers, and pelvic discharge, suspected of having Pelvic Inflammatory Disease (PID)?
What is the best treatment approach for a patient with chronic Pelvic Inflammatory Disease (PID) symptoms?
Can Tigecycline (tigecycline) and Targocid (teicoplanin) be combined for antibiotic therapy in an adult patient with a hospital-acquired infection or complicated skin and soft tissue infection caused by resistant bacteria, including MRSA (methicillin-resistant Staphylococcus aureus)?
What is the maximum recommended dose of losartan (angiotensin II receptor antagonist) for an adult patient with hypertension, considering factors such as impaired renal (kidney) function, hepatic impairment, diabetes, and geriatric status?
What is the best treatment for an elderly patient with an unstageable coccyx pressure injury with slough who cannot tolerate debridement?
What is the management strategy for a patient with type 1 diabetes (T1D) and impaired renal function, as indicated by proteinuria?
What medication adjustments can be made for a 13-year-old male patient with Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and a history of porn addiction, who is currently taking fluoxetine (Prozac) 20mg daily and is part of a Partial Hospitalization Program (PHP), but still exhibits depressive symptoms?
What is the best approach to manage hidradenitis suppurativa (HS) in a postpartum patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.